We hypothesised that the combined analysis of several of these molecular markers (Figure 1), which provides information on the activity/sensitivity of the EGFR signalling pathway at different points, is related to the prognosis of NSCLC patients when analysed in combination. Here, EGFR is linked to non-small cell lung carcinoma.